Claim 30% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
The latest update is out from Ibio (IBIO).
iBio, Inc. has updated its employment agreement with CEO and Chief Scientific Officer Martin Brenner, offering him a base salary of $522,365 and a raised bonus target of 50% for fiscal year 2025. Brenner’s employment is at-will but includes comprehensive termination benefits, such as a year’s base salary and potential COBRA coverage following his departure. In case of a company sale, these benefits extend to eighteen months’ salary and health insurance, along with accelerated equity award vesting. Brenner is also bound by non-solicitation clauses and must assign any inventions made during his tenure to the company.
For detailed information about IBIO stock, go to TipRanks’ Stock Analysis page.